CALL - SPRINTER OPEN END - FRESENIUS MEDICAL CARE Share Price

Certificat

DE000VU13GX1

Market Closed - Deutsche Boerse AG 19:02:01 05/07/2024 BST
6.92 EUR +4.22% Intraday chart for CALL - SPRINTER OPEN END - FRESENIUS MEDICAL CARE
Current month+5.49%
1 month-31.89%
Date Price Change
05/07/24 6.92 +4.22%
04/07/24 6.64 +3.75%
03/07/24 6.4 -1.39%
02/07/24 6.49 -3.13%
01/07/24 6.7 +2.13%

Delayed Quote Deutsche Boerse AG

Last update July 05, 2024 at 07:02 pm

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying FRESENIUS MEDICAL CARE AG
IssuerLogo Issuer Vontobel Vontobel
WKN VU13GX
ISINDE000VU13GX1
Date issued 11/01/2023
Strike 29.3
Maturity Unlimited
Parity 1 : 1
Emission price 4.41
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 21.4
Lowest since issue 2.15

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
36.16 EUR
Average target price
39.97 EUR
Spread / Average Target
+10.55%
Consensus